NSABP B-51/RTOG 1304

ATTENTION! SITES NOT Using the NCI Central IRB (CIRB)

July 25, 2016

NSABP B-51/RTOG 1304 A Randomized Phase III Clinical Trial Evaluating Post-Mastectomy Chestwall and Regional Nodal XRT and Post-Lumpectomy Regional Nodal XRT in Patients with Positive Axillary Nodes Before Neoadjuvant Chemotherapy Who Convert to Pathologically Negative Axillary Nodes after Neoadjuvant Chemotherapy

Effective immediately, sites NOT using the NCI Central IRB (CIRB) and that have not yet submitted an Amendment #3 approval to the CTSU will not be able to enroll patients until an Amendment #3 IRB approval has been submitted to CTSU.

Further details are posted to the B-51/1304 page on the NSABP and CTSU websites.

Twitter
View this email in your browser
You are receiving this email because of your relationship with NRG Oncology. Please reconfirm your interest in receiving emails from us. If you do not wish to receive any more emails, you can unsubscribe here.

Four Penn Center 1600 JFK Blvd. Suite1020 , Philadelphia, PA, 19103


Update Profile/Email Address